About LA CaTS

News

LSU Health New Orleans Participating in NIH COVID-19 Antibody Treatment Trial at UMC

Released: Monday, December 21, 2020

LA CaTS Member Institutions, LSU Health Sciences Center-New Orleans and University Medical Center, are participating in one of four clinical trials from NIH’s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Program. This particular trial will test the safety and effectiveness of monoclonal antibodies as a potential coronavirus treatment.

Click HERE to view the full article from the LSU Health New Orleans News Room site.

###

About the Louisiana Clinical and Translational Science (LA CaTS) Center
The LA CaTS Center is comprised of three primary collaborating institutions in the state, including LSU's Pennington Biomedical Research Center in Baton Rouge, LSU Health Sciences Center in New Orleans, and Tulane University School of Medicine in New Orleans – and also includes six research partners: LSU Health Sciences Center in Shreveport, Louisiana State University in Baton Rouge, and in New Orleans, Xavier University of Louisiana, Children’s Hospital, Ochsner Health System, Southeast Louisiana Veterans Health Care System, and University Medical Center.  The LA CaTS Center’s vision for Louisiana encompasses the strengths and capacities unique to each member institution and represents a unified, comprehensive approach for targeting prevention, care and research of chronic diseases in the underserved population.  The scholar program is supported in part by U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center.  For more information, please visit www.lacats.org.